均瑤健康(605388.SH):涉及幽門螺桿菌領域的咀嚼片、飲品等產品尚處於產品投入階段
格隆匯1月6日丨均瑤健康(605388.SH)公佈股票交易異常波動公吿,公司股票價格於2022年1月4日、5日、6日連續三個交易日內日收盤價格漲幅偏離值累計超過20%。根據上海證券交易所的相關規定,屬於股票交易異常波動情形。
經公司董事會自查及發函問詢控股股東及實際控制人,截至公吿披露日,不存在應披露而未披露的重大信息。
截至2022年1月6日收盤,公司股票於2022年1月6日的滾動市盈率為59.41倍,高於同行業的平均水平。
目前公司主營業務仍為乳酸菌飲品,公司涉及到幽門螺桿菌領域的咀嚼片、飲品等產品尚處於產品投入階段。截至公司2021年前三季度,上述產品收入佔比小於公司營業收入的5%(該數據未經審計),對公司經營業績影響很小。
2021年前三季度,公司實現營業收入70,039.99萬元,同比下降1.36%;實現歸屬於上市公司股東的淨利潤14,401.35萬元,同比減少27.04%;實現歸屬於上市公司股東的扣除非經常性損益的淨利潤10,436.11萬元,同比減少35.55%。公司敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.